279 related articles for article (PubMed ID: 23945276)
1. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.
Pegoraro S; Ros G; Piazza S; Sommaggio R; Ciani Y; Rosato A; Sgarra R; Del Sal G; Manfioletti G
Oncotarget; 2013 Aug; 4(8):1293-308. PubMed ID: 23945276
[TBL] [Abstract][Full Text] [Related]
2. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
3. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
[TBL] [Abstract][Full Text] [Related]
4. HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc.
Li Z; Liu J; Chen T; Sun R; Liu Z; Qiu B; Xu Y; Zhang Z
J Exp Clin Cancer Res; 2021 Mar; 40(1):86. PubMed ID: 33648560
[TBL] [Abstract][Full Text] [Related]
5. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
6. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
7. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
Di Cello F; Shin J; Harbom K; Brayton C
Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
[TBL] [Abstract][Full Text] [Related]
9. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
[TBL] [Abstract][Full Text] [Related]
10. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
[TBL] [Abstract][Full Text] [Related]
11. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.
Huang R; Huang D; Dai W; Yang F
Mol Cell Biochem; 2015 Jun; 404(1-2):251-7. PubMed ID: 25772486
[TBL] [Abstract][Full Text] [Related]
14. Non-canonical Fzd7 signaling contributes to breast cancer mesenchymal-like stemness involving Col6a1.
Yin P; Bai Y; Wang Z; Sun Y; Gao J; Na L; Zhang Z; Wang W; Zhao C
Cell Commun Signal; 2020 Sep; 18(1):143. PubMed ID: 32894152
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.
Puca F; Colamaio M; Federico A; Gemei M; Tosti N; Bastos AU; Del Vecchio L; Pece S; Battista S; Fusco A
Oncotarget; 2014 May; 5(10):3234-45. PubMed ID: 24833610
[TBL] [Abstract][Full Text] [Related]
16. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
17. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
18. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
[TBL] [Abstract][Full Text] [Related]
20. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
